Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04586231 |
|---|---|
| Brief Title: | A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011) |
| First Submitted : | October 9, 2020 |
| First Submitted that Met QC Criteria : | October 9, 2020 |
| First Posted : | October 14, 2020 |
| Last Update Submitted that Met QC Criteria : | May 17, 2024 |
| Last Update Posted : | May 17, 2024 |